Dongwei Xu

1.5k total citations
47 papers, 1.1k citations indexed

About

Dongwei Xu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Dongwei Xu has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Dongwei Xu's work include Autophagy in Disease and Therapy (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and MicroRNA in disease regulation (5 papers). Dongwei Xu is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and MicroRNA in disease regulation (5 papers). Dongwei Xu collaborates with scholars based in China, United States and United Kingdom. Dongwei Xu's co-authors include Qiang Xia, Xiaoni Kong, Hailong Wu, Bibo Ke, Min Xu, Seogsong Jeong, Yizhu Tian, Yihan Qian, Mingwei Sheng and Douglas G. Farmer and has published in prestigious journals such as Hepatology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Dongwei Xu

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongwei Xu China 20 516 318 237 193 188 47 1.1k
Hyuk Soo Eun South Korea 20 460 0.9× 420 1.3× 282 1.2× 161 0.8× 278 1.5× 68 1.3k
Cheng Ma China 17 512 1.0× 320 1.0× 215 0.9× 78 0.4× 187 1.0× 25 1.1k
Ran Fei China 20 429 0.8× 314 1.0× 458 1.9× 117 0.6× 284 1.5× 85 1.4k
Shuncai Zhang China 27 614 1.2× 481 1.5× 247 1.0× 235 1.2× 353 1.9× 43 1.6k
Terumi Takahara Japan 22 395 0.8× 409 1.3× 170 0.7× 302 1.6× 402 2.1× 65 1.4k
Zhiming Huang China 23 713 1.4× 335 1.1× 381 1.6× 246 1.3× 154 0.8× 71 1.7k
Takashi Kagaya Japan 15 522 1.0× 239 0.8× 554 2.3× 256 1.3× 274 1.5× 39 1.7k
Dandan Zhou China 11 378 0.7× 304 1.0× 108 0.5× 126 0.7× 316 1.7× 16 998
Chuantao Tu China 24 425 0.8× 579 1.8× 216 0.9× 151 0.8× 453 2.4× 38 1.4k
Jin Ye China 18 446 0.9× 245 0.8× 90 0.4× 197 1.0× 103 0.5× 63 1.0k

Countries citing papers authored by Dongwei Xu

Since Specialization
Citations

This map shows the geographic impact of Dongwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Xu more than expected).

Fields of papers citing papers by Dongwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Xu. The network helps show where Dongwei Xu may publish in the future.

Co-authorship network of co-authors of Dongwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Xu. A scholar is included among the top collaborators of Dongwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Xu. Dongwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Alec, Dongwei Xu, David Osumi-Sutherland, et al.. (2025). Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1-induced endoplasmic reticulum-associated degradation. Cell Reports. 44(4). 115459–115459. 1 indexed citations
2.
Xu, Dongwei, Yichun Luo, Fang Wang, et al.. (2024). Osteopontin Depletion in Nonhematopoietic Cells Improves Outcomes in Septic Mice by Enhancing Antimicrobial Peptide Production. The Journal of Infectious Diseases. 230(5). e1146–e1157. 1 indexed citations
3.
Ye, Song, et al.. (2023). Evaluation of Contrast-Enhanced Ultrasound in Diagnosis of Acute Kidney Injury of Patients in Intensive Care Unit. International Journal of General Medicine. Volume 16(264). 2229–2236. 4 indexed citations
4.
Xu, Dongwei, Alec Vincent, Andrés González‐Gutiérrez, et al.. (2023). A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer’s disease models. PLoS Genetics. 19(9). e1010893–e1010893. 8 indexed citations
5.
Yang, Tao, Xiao Wang, Dongwei Xu, et al.. (2023). The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets. Hepatology. 80(5). 1169–1183. 29 indexed citations
6.
Qu, X. B., Tao Yang, Xiao Wang, et al.. (2023). Macrophage RIPK3 triggers inflammation and cell death via the XBP1–Foxo1 axis in liver ischaemia–reperfusion injury. JHEP Reports. 5(11). 100879–100879. 16 indexed citations
7.
Zhong, Min‐Er, Xin Duan, Mayidili Nijiati, et al.. (2022). CT-based radiogenomic analysis dissects intratumor heterogeneity and predicts prognosis of colorectal cancer: a multi-institutional retrospective study. Journal of Translational Medicine. 20(1). 574–574. 13 indexed citations
8.
Xu, Min, Hualian Hang, Miao Huang, et al.. (2021). DJ-1 Deficiency in Hepatocytes Improves Liver Ischemia-Reperfusion Injury by Enhancing Mitophagy. Cellular and Molecular Gastroenterology and Hepatology. 12(2). 567–584. 26 indexed citations
9.
Jiang, Xue, Yan Hu, Dongwei Xu, et al.. (2021). Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission. Experimental and Therapeutic Medicine. 22(5). 1250–1250.
10.
Sheng, Mingwei, Yuanbang Lin, Dongwei Xu, et al.. (2021). CD47‐Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation in Mouse Liver Inflammation. Hepatology. 74(3). 1560–1577. 41 indexed citations
11.
Xia, Lei, et al.. (2021). Metformin suppresses interleukin‐22 induced hepatocellular carcinoma by upregulating Hippo signaling pathway. Journal of Gastroenterology and Hepatology. 36(12). 3469–3476. 17 indexed citations
12.
13.
Chang, Ling, et al.. (2020). Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives. Frontiers in Pharmacology. 11. 313–313. 33 indexed citations
14.
Jin, Yuting, Changyong Li, Dongwei Xu, et al.. (2019). Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cellular and Molecular Immunology. 17(12). 1245–1256. 71 indexed citations
15.
Li, Meng, Min Xu, Jichang Li, et al.. (2018). Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice. Journal of Immunology Research. 2018. 1–14. 18 indexed citations
16.
Xu, Dongwei, et al.. (2018). [Value of Hepcidin as a diagnostic biomarker of sepsis in critically ill adults].. PubMed. 30(7). 652–657. 7 indexed citations
17.
Xu, Dongwei, Lili Chen, Xiaosong Chen, et al.. (2017). The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy. Cell Death and Disease. 8(8). e2983–e2983. 106 indexed citations
18.
Li, Dawei, Dongwei Xu, Jiang Zhang, et al.. (2015). A Potential Profibrogenic Role of Biliary Epithelium-Derived Cardiotrophin-1 in Pediatric Cholestatic Liver Disease. Journal of Interferon & Cytokine Research. 35(8). 606–612. 4 indexed citations
19.
Xu, Dongwei, et al.. (2015). Autophagy in Tumorigenesis and Cancer Treatment. Asian Pacific Journal of Cancer Prevention. 16(6). 2167–2175. 20 indexed citations
20.
Zeng, Weiwei, et al.. (2013). A one‐step molecular biology method for simple and rapid detection of grass carp Ctenopharyngodon idella reovirus (GCRV) HZ08 strain. Journal of Fish Biology. 82(5). 1545–1555. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyuk Soo Eun Breakdown of academic impact, for papers by Cheng Ma Breakdown of academic impact, for papers by Ran Fei Breakdown of academic impact, for papers by Shuncai Zhang Breakdown of academic impact, for papers by Terumi Takahara Breakdown of academic impact, for papers by Zhiming Huang Breakdown of academic impact, for papers by Takashi Kagaya Breakdown of academic impact, for papers by Dandan Zhou Breakdown of academic impact, for papers by Chuantao Tu Breakdown of academic impact, for papers by Jin Ye
Rankless by CCL
2026